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https://doi.org/10.1016/j.celrep.2019.01.094SUMMARY
Large cohorts of human induced pluripotent stem
cells (iPSCs) from healthy donors are a potentially
powerful tool for investigating the relationship be-
tween genetic variants and cellular behavior. Here,
we integrate high content imaging of cell shape,
proliferation, and other phenotypeswith gene expres-
sion and DNA sequence datasets from over 100 hu-
man iPSC lines. By applying a dimensionality reduc-
tion approach, Probabilistic Estimation of Expression
Residuals (PEER), we extracted factors that captured
the effects of intrinsic (genetic concordance between
different cell lines from the same donor) and extrinsic
(cell responses todifferent fibronectin concentrations)
conditions.We identify genes that correlate in expres-
sion with intrinsic and extrinsic PEER factors and
associate outlier cell behavior with genes containing
rare deleterious non-synonymous SNVs. Our study,
thus, establishes a strategy for examining the genetic
basis of inter-individual variability in cell behavior.INTRODUCTION
Now that the applications of human induced pluripotent stem
cells (hiPSCs) for disease modeling and drug discovery are2078 Cell Reports 26, 2078–2087, February 19, 2019 ª 2019 The Aut
This is an open access article under the CC BY license (http://creativewell established, attention is turning to the creation of large co-
horts of hiPSCs from healthy donors. These offer a unique op-
portunity to examine common genetic variants and their effects
on gene expression and cellular phenotypes (Warren et al., 2017;
Pashos et al., 2017; Carcamo-Orive et al., 2017; DeBoever et al.,
2017; Kilpinen et al., 2017). Genome-wide association studies
(GWASs) and quantitative trait locus (QTL) studies can be used
to correlate SNPs and other genetic variants with quantitative
phenotypes (Panopoulos et al., 2017). As a contribution to this
effort, we recently described the generation and characterization
of over 700 open access hiPSC lines derived from 301 healthy
donors through the Human Induced Pluripotent Stem Cell Initia-
tive (HipSci) (Kilpinen et al., 2017; www.hipsci.org). In addition to
creating a comprehensive reference map of common regulatory
variants affecting the transcriptome of hiPSCs, we performed
quantitative assays of cell morphology and demonstrated a
donor contribution in the range of 8%–23% to the observed vari-
ation (Kilpinen et al., 2017). In the present study, we set out to
identify genetic drivers of cell behavior.
Previous attempts using lymphoblastoid cell lines to link ge-
netics to in vitro phenotypes have had limited success (Choy
et al., 2008; Jack et al., 2014). In that context, confounding ef-
fects included Epstein Barr virus (EBV) viral transformation, the
small number of lines analyzed, variable cell culture conditions,
and line-to-line variation in proliferation rate. These factors
decrease the power to detect true relationships between DNA
variation and cellular traits (Choy et al., 2008). In contrast, we
have access to a large number of hiPSC lines derived usinghors.
commons.org/licenses/by/4.0/).
standard protocols from healthy volunteers, including multiple
lines from the same donor. In addition, HipSci lines present a
substantially lower number of genetic aberrations than reported
for previous collections (Kilpinen et al., 2017; Laurent et al.,
2011). Cells are examined over a limited number of passages,
and cell properties are evaluated at single-cell resolution during
a short time frame, using high-throughput quantitative readouts
of cell behavior.
Stem cell behavior reflects both the intrinsic state of the cell
(Choi et al., 2015; Kytta¨la¨ et al., 2016) and the extrinsic signals
it receives from its local microenvironment, or niche (Lane
et al., 2014; Reimer et al., 2016). We hypothesized that subject-
ing cells to different environmental stimuli increases the likeli-
hood of uncovering links between genotype and cell behavior.
For that reason, we seeded cells on different concentrations of
the extracellular matrix (ECM) protein fibronectin that support
cell spreading to differing extents and assayed the behavior of
single cells and cells in contact with their neighbors. We took a
‘‘cell observatory’’ approach, using high-throughput, high-con-
tent imaging to gather data from millions of cells 24 h after seed-
ing. We then applied a multidimensional reduction method,
Probabilistic Estimation of Expression Residuals (PEER) (Stegle
et al., 2012), to reveal the underlying structure in the dataset and
correlated cell behavior with the expression of a subset of genes
and the presence of rare deleterious non-synonymous single
nucleotide variants (nsSNVs). The strategy we have developed
bridges the gap between genetic and transcript variation on
the one hand and cell phenotype on the other, and should be
of widespread utility in exploring the genetic basis of inter-indi-
vidual variability in cell behavior.
RESULTS
Generation and Characterization of the Lines
Weanalyzed 110 cell lines, 107 from theHipSci resource (Kilpinen
et al., 2017) and 3 non-HipSci control lines (Table S1). Of these,
99 lines were reprogrammed by Sendai virus and 11 using
episomal vectors. A total of 100 lines came from 65 healthy
researchvolunteers; thus, several lineswerederived fromdifferent
clones from the same donor. Seven lines came from 7 individuals
with Bardet-Biedl syndrome.Out of the total, 102 of the lineswere
derived from skin fibroblasts, 6 from peripheral blood monocytes
and 2 from hair follicles. Lines were subjected to the quality con-
trols specified within the HipSci production pipeline, including
highPluriTest (StemCell Assays) scores and the ability to differen-
tiate along the three embryonic germ layers. All the cell lines were
reprogrammed on feeders, and all but 6 lines were cultured on
feeders prior to phenotypic analysis (Table S1). Most cells were
examined between passages 15 and 45 (Table S1).
Cell Behavior Assays
To quantitate cell behavior at single-cell resolution, we used the
high-content imaging platform that we described previously
(Leha et al., 2016). Cells were disaggregated and resuspended
in the presence of 10-mM Rho-associated protein kinase
(ROCK) inhibitor to minimize cell clumping. In order to vary the
extrinsic conditions for cell adhesion and spreading, cells were
seeded on 96-well plates coated with 3 different concentrationsof fibronectin, namely, 1, 5, and 25 mg/mL (Fn1, Fn5, and Fn25,
respectively), with Fn1 representing a suboptimal concentration
for cell attachment and spreading. After 24 h of culture in the
presence of the ROCK inhibitor, cells were labeled with 5-ethy-
nyl-20-deoxyuridine (EdU) for 30min (to detect proliferative cells),
fixed, and stained with 40,6-diamidino-2-phenylindole (DAPI) (to
visualize nuclei) andCellMask (to visualize cytoplasm) (Figure 1A;
Figure S1A). qPCR (Figure S1B) and antibody labeling (Fig-
ure S1A) confirmed that pluripotency was maintained at 24 h,
regardless of FN concentration. In addition, when cells were har-
vested from FN and replated, they were able to form colonies
containing a majority of Oct4- and NANOG-positive cells (Fig-
ures S1C and S1D).
Three replicate wells were seeded per cell line, and each cell
line was analyzed in up to three independent experiments. Wells
containing technical triplicates of each fibronectin concentration
were randomized per column (e.g., 1-5-25; 5-25-1; 25-1-5) to
obviate edge and position effects. Technical replicates of the
same cell line were randomized in rows and one line, previously
reported as A1ATD-iPSC patient 1 (Rashid et al., 2010), was
included to control for biological variation between experiments.
From each of approximately 2 million cells, we extracted a to-
tal of 11 measurements, 10 per cell (i.e., object-based), plus the
number of cells per well (i.e., well-based) (Figures 1B-1D). Cell
features included the derived area, roundness, and width to
length ratio of each cell and each nucleus. We also determined
clump size, a context feature representing the number of cells
in a group that were in contact with one another. We then
measured the features of individual solitary cells and individual
cells within a group (Figures 1B–1D). Some features were posi-
tively correlated with one another, such as cell area and nuclear
area, whereas in other cases, such as cell area and cell round-
ness, there was an inverse correlation (Figure 1C). The pheno-
typic features were processed as described previously (Leha
et al., 2016), i.e., well-based measurements were normalized in
value (log10 or square transformation) and aggregated across
the cells in each well by taking the average and standard devia-
tion. For EdU incorporation, median pixel intensity raw values per
cell were used to extract a well-based measure of the fraction of
EdU-positive cells (Leha et al., 2016). This resulted in a final list of
52 features (Table S2).
The scale and complexity of the cell phenotype dataset is illus-
trated in Figure 1F, in which the mean value of cell area is repre-
sented for all cell lines, for three fibronectin concentrations and
three biological replicates (batches; gray bars indicate replicates
that were not performed). This highlights the variance we
observed between replicate experiments. It also reveals the
extent of variability for cell lines derived from the same donor, de-
noted by a common 4-letter code (Figure 1F). It shows a consis-
tent effect of fibronectin concentration on cell behavior, with
cells exhibiting a smaller spread area on the lowest concentra-
tion (see also Figure 1D). Figure 1E shows that fibronectin con-
centration has a significant effect on cell area and that the effect
is greater than the variance between cell lines and between bio-
logical replicates. Similar results were obtained for other raw
phenotypic features (Figure S2). We conclude that FN concen-
tration, which is an extrinsic or environmental factor, influences
cell behavior regardless of the donor origin of each cell line.Cell Reports 26, 2078–2087, February 19, 2019 2079
Figure 1. Description of Phenotypic Dataset
(A) Microscopic image showing cells 24 h after plating. Red: cell mask (cytoplasm); white: EdU incorporation (DNA synthesis, one EdU+ cell markedwith asterisk);
blue: DAPI (nuclei). Scale bar: 20 mm.
(B) Schematic of phenotypic features measured in this study.
(C) Correlation of different phenotypic measurements in all cells.
(D) Distribution of main phenotypic features of all cell lines on three fibronectin concentrations (Fn1, red; Fn5, green; Fn25, blue). y axis: density measurements
represent the cell number distributions.
(E) Boxplots of mean cell area on three fibronectin concentrations in three biological replicates (batches). Each dot is one cell line. Asterisks (****p % 0.0001)
represent significance values from pairwise t tests performed between each condition.
(F) Heatmap of mean cell area measurements for each cell line on three fibronectin concentrations in three independent experiments. Grey boxes correspond to
replicates not performed.Identification of Outlier Cell Lines
Having established that FN concentration, an extrinsic factor, in-
fluences cell behavior, we next examined whether individual cell
lines exhibited outlier FN responses as a potential route to
exploring genetic (intrinsic) contributions to cell phenotype.
Outlier cell lines were defined as lines that deviated significantly
frommodal phenotypic values. To identify them, we performed a
Kolmogorov-Smirnov test of the distributions of each raw
phenotypic feature for each individual cell line compared to all
cell lines (Figure 2). We arbitrarily defined outliers as cell lines2080 Cell Reports 26, 2078–2087, February 19, 2019with a statistic (D) value above the 95th percentile. Out of the
110 lines analyzed, 36 lines from 30 donors exhibited outlier
behavior for one or more phenotypic feature (Figure 2;
Figure S3).
In support of a genetic contribution to outlier cell behavior, in
several cases two independent lines from the same donor ex-
hibited the same outlier behavior. For example iakz_1 and
iakz_2 were outliers for cell roundness, whereas airc_2 and
airc_3 were outliers for DAPI nuclear staining intensity. In
addition, where two phenotypes were positively or negatively
Figure 2. Identification of Outlier Cell Lines for Individual Phenotypes
The distribution of the Kolmogorov-Smirnov statistic (D) obtained by performing the Kolmogorov-Smirnov test of the distributions of each raw phenotypic feature
for each individual cell line compared to all cell lines. 95th percentile threshold is shown as a red line together with values of individual outlier lines (color coded).
Lines listed in italic bold correspond to lines having outlier measurements in more than one batch.correlated (e.g., cell area and cell roundness), some cell lines
were outliers in both categories (e.g., iakz_1).
Applying PEER to Discover Determinants of Variation in
Cell Behavior
In order to explore how extrinsic (i.e., different fibronectin con-
centrations), intrinsic (i.e., cell line donor specific), and technical
or biological components (covariates) contributed to the
observed variation in cell phenotypes, we applied a dimension-
ality reduction approach called Probabilistic Estimation of
Expression Residuals (PEER) (Stegle et al., 2012). PEER is a soft-
ware package that implements Bayesian statistical models that
improve the sensitivity and interpretability of genetic associa-
tions in population-scale data. It takes as input gene transcript
profiles and covariates from a set of individuals and then outputs
hidden factors (PEER factors) that explain the expression vari-
ability. Many previous studies have demonstrated the impor-
tance of accounting for hidden factors to achieve a stronger sta-
tistical discrimination signal (Leek and Storey, 2007; Stegle et al.,
2008; Kang et al., 2008). Here, we have applied PEER to multidi-
mensional reduction of cell phenotypic data.
In our analysis, we input the 52 phenotypic measurements
(Table S2), the 3 covariates (i.e., fibronectin concentrations,experimental replicates, and individual donors), and the esti-
mated total number of unobserved factors (k). To obtain this
number, the PEER analysis was repeated several times with a
range of values of k (from 1 to 13), and for each k the inverse
of the variance of the factor weight was calculated with auto-
matic relevance determination (ARD) (Stegle et al., 2012) (Fig-
ure S4A). The plot of the inverse variance of factor weights
against the k number (usually observed as an ‘‘elbow’’) shows
that above k = 9, the inverse variance begins to rise, indicating
that there is no additional benefit of increasing k further (Fig-
ure S4A). Thus, in our analysis, a total of 9 PEER factors could ac-
count for the observed variance in cell behavior.
We next evaluated whether any PEER factor(s) captured the
variance in cell behavior due to the different fibronectin concen-
trations (Figure 3). The effect of fibronectin was statistically signif-
icant (paired t test) for all three concentrations in the case of Fac-
tors 1, 3, and 7 (Figure 3). Of those, PEER Factor 1 was the factor
that best captured the variance based on statistical analysis. All of
the other variance in cell phenotypes attributable to the different
fibronectin concentrations (including mean and standard devia-
tion of total number of attached cells, cell and nucleus area and
DAPI staining intensity) was also captured by PEER Factor 1 to
a greater extent than the other factors (Figure S4B).Cell Reports 26, 2078–2087, February 19, 2019 2081
Figure 3. Synthetic Phenotypic Features Capture Extrinsic and Intrinsic Contributions to Variance
Plots showing the distribution of values for the 9 PEER Factors (F1–F9). Left andmiddle columns show distributions for three fibronectin concentrations (Fn1, red;
Fn5, green; Fn25, blue). Asterisks represent significance values from pairwise t tests performed between each fibronectin condition (****p% 0.0001; ***p% 0.001;
**p% 0.01; *p% 0.05; ns, not significant). Right-hand column shows the donor-concordance between two clonal lines of cells derived from the same donors.
Values for one cell line in each pair are shown on the x axis and its ‘‘twin’’ on the y axis. Each dot corresponds to one cell line.We previously reported a donor contribution in the range of
8%–23% to the observed variation in cell behavior (Kilpinen
et al., 2017). We therefore hypothesized that one or more
PEER factors would capture structure in the data that was
dependent on the genetic background of the donors from
whom the cell lines were generated. In the cases where we
had cell behavior data for two independent lines from the same
donor, we plotted phenotypic data for one of the cell lines on
the x axis and the other (‘‘twin’’) cell line on the y axis. Donor
concordance is indicated by a positive correlation between the
measurements for each pair of lines. This was highest in the
case of PEER Factor 9, and therefore this was the factor that
best captured intrinsic variance (Figure 3). Phenotypic features
describing EdU labeling and other nuclear properties, both in
single and clumped cells, loaded onto PEER Factor 9 (Fig-
ure S4B). PEER Factor 9 did not capture any of the variation
due to FN concentration (Figure 3).2082 Cell Reports 26, 2078–2087, February 19, 2019Identification of Genes Correlating with Extrinsic and
Intrinsic Variation
To identify genes whose expression correlated with phenotypic
variance, we performed a correlation analysis between the
intrinsic (PEER Factor 9) and extrinsic (PEER Factor 1) factors
and gene expression array data independently generated from
cell pellets as part of the HipSci resource. The gene expression
datasets were generated from cell lines between passages
8–41. There was no significant variation in the RNA sequencing
(RNA-seq) expression of the majority of genes, including
pluripotency factors NANOG and OCT4, with passage number
(Kilpinen et al., 2017).
The expression of 4,573 genes correlated with PEER Factor 1
(PEER 1) or PEER 9, or both factors, in at least one fibronectin
concentration (Table S3). These genes could be a mixture of
genes that are causal, proxy, or a consequence of the cellular
trait captured by PEER. From this list, we filtered out genes
Figure 4. Using the ‘‘Extrinsic’’ and
‘‘Intrinsic’’ PEER Factors to Identify Genes
That Correlatewith SpecificCell Phenotypes
(A) Heatmap showing the 3,879 genes correlated
with either extrinsic PEER Factor 1, intrinsic Factor
9, or both. Color scale depicts correlation values.
(B) GO analysis of genes correlating with PEER 1
(blue circles), PEER 9 (orange circles), or both
factors (gray circles). All GO terms for the factors
are shown. Circle size represents the frequency of
the GO term in the underlying Gene Ontology
Annotation (GOA) database; red color scale in-
dicates p value. Each gene was mapped to the
most specific terms applicable in each ontology.
Highly similar GO terms are linked by edges, with
edge width depicting the degree of similarity.
Terms in black font were used to select the list of
175 genes in Table S3.
(C) In 98 out of 175 genes, gene expression
correlated significantly with cell area, tendency to
form clumps (‘‘clumpiness’’), number of cells, and/
or proliferation. The colors of the points corre-
spond to the correlation values, while the shapes
indicate correlation of a specific gene to the
extrinsic (PEER 1; oval), intrinsic (PEER 9; rect-
angle) or both (triangles) factors. Grey dotted
vertical lines separate genes correlating with one,
two or four phenotypes (left to right).
(D) Boxplots showing the expression values (vsn)
of 32 out of the 38 genes (Table S5) with outlier
gene expression in one or more outlier cell line.
Color code (blue, orange, gray) as in (B).that were not associated with any Ensembl identifiers. We also
removed genes for which multiple probes showed opposite cor-
relation values. The resulting dataset consisted of 3,879 genes
(Table S3), 1,321 correlating with PEER 1, 1,977 correlating
with PEER 9, and 581 with both (Figure 4A).
Gene Ontology (GO) analysis was performed on the 3,879
genes at a threshold value of ±0.2 of the correlation coefficient
(Figure 4B; Table S4). All of the GO terms associated with
PEER 1 and PEER 9 are shown in Figure 4B. GO terms associ-
ated with PEER 1 included cell adhesion and receptor serine
and threonine kinase signaling. Terms associated with PEER 9
included cell proliferation, response to stress, and integrin-medi-
ated cell adhesion. Only two GO terms were associated with
both PEER factors: membrane organization and cell-matrix
adhesion.
Based on the phenotypes measured in our study, we further
filtered the genes according to the functions of their protein
products. Because we measured EdU incorporation, the rele-
vant GO terms are cell cycle and regulation of cell proliferation.
Cell-extracellular matrix adhesion is the relevant GO term to cap-
ture adhesion to fibronectin. We alsomeasured adhesion of cells
in groups, and therefore cell-cell adhesion is the relevant GOCell Repoterm. The additional GO termsmembrane
organization and transmembrane recep-
tor signaling are relevant to all the
measured phenotypes: proliferation,
ECM adhesion, and cell-cell adhesion(Table S2). Within the 3,879 genes correlating with either or
both PEER Factors, 175 genes belonging to these 6 GO cate-
gories were found. The expression of 98 out of the 175 genes
showed a statistically significant correlation with at least 1 of
our raw phenotypic features (Table S3). The importance of per-
forming a dimensionality reduction analysis on the phenotypic
data and then using the selected factors for the correlation
with gene expression data instead of raw phenotypes is
confirmed by the quantile (Q-Q) plots in Figure S4C.
Examples of gene expression variation among cell lines for
genes correlating with one, two, three, or four phenotypic fea-
tures (cell number, proliferation, cell clumping, and cell area)
are shown in Figure 4C. We noted that most genes showed
distinct correlations with the PEER factors (Figure 4C; Table
S3). In addition, opposite correlations were found for a given
gene and one or more phenotypes. For example, ITGAL, which
mediates intercellular adhesion, was positively correlated with
clumping and negatively correlated with proliferation.
A total of 38 out of 175 genes showed outlier expression (5th
and 95th percentiles) in one or more cell line (Figure 4D). The ma-
jority of these genes (32 out of 38) were outliers in outlier cell lines
(Table S5). The only outlier gene exclusively associated withrts 26, 2078–2087, February 19, 2019 2083
Figure 5. Identification of Rare, Deleterious,
and Destabilizing nsSNVs That Correlate
with Outlier Cell Behavior
(A) Analysis pipeline for selection of genes. The
3,879 genes associated with PEER 1 and 9 were
screened for nsSNVs in over 700 cell lines from the
HipSci resource and further filtered as shown.
(B) Genes with at least one rare, deleterious, and
destabilizing nsSNV in at least one cell line found to
be an outlier for one or more phenotype. See Fig-
ure 2 for outlier KS analysis. Genes correlating with
PEER Factor 1: blue; PEER Factor 9: orange; both:
gray. The phenotypes of cell area, cell roundness,
and nucleus roundness were significantly over-
represented in outlier cell lines with one or more
deleterious and destabilizing nsSNV (p% 0.05).
(C) Representative images of outlier cell line
yuze_1 (top), control cell line A1ATD-iPSC patient 1
(center), and cell line not analyzed in the original
screen ffdc_11 (bottom), on different fibronectin
concentrations (Fn1, Fn5, and Fn25).
(D) Protein structures of integrin a6 (top) and in-
tegrin b1 (bottom). nsSNVs detected in the two cell
lines are shown with yellow spots indicated by red
arrows.PEER 9 was SRC, proto-oncogene tyrosine-protein kinase.
However, in cases in which two cell lines from the same donor
were outliers for the same raw phenotypic features (Figure 2),
this did not correlate with an overexpression or lack of expres-
sion of the same set of genes.
In conclusion, we could identify a large number of mRNAs that
correlated with modal cell behavior and a smaller number that
correlated with outlier behavior. The GO terms were, for the
most part, those that would be predicted to be associated with
the types of phenotypic measurement that we recorded.
Identification of nsSNVs in Cell Adhesion Genes that
Correlate with Outlier Cell Phenotypes
Because most of the mRNAs loading onto PEER 1 and PEER 9
correlated with modal, rather than outlier cell behavior, we
explored the alternative hypothesis that the presence of single
nucleotide variants (nsSNVs) in gene exons that affected protein
function would correlate with outlier cell behavior. We searched
all the cell lines in the Hipsci resource (>700 lines) for nsSNVs in
the 3,879 genes (Table S3) identified with the extrinsic and
intrinsic PEER factors (Figure 5A; Table S6). Of the 10,2572084 Cell Reports 26, 2078–2087, February 19, 2019nsSNVs identified, 4,495 were classified
as rare, based first on the 1000 Genomes
Project Consortium (2015) and ExAC (Lek
et al., 2016) and second on the frequency
in our cell lines (present in fewer than 5 out
of 110 lines) (Figure 5A).We further filtered
the nsSNVs by using the computational
model DUET (Pires et al., 2014) to predict
nsSNVs that would be deleterious and the
computational model Condel (Gonza´lez-
Pe´rez and Lo´pez-Bigas, 2011) to predict
a final list of 103 rare, deleterious, and de-stabilizing nsSNVs that would impair protein structure. Among
the genes that we identified (Table S6), several encoded proteins
were associated with cell adhesion, including integrins and cyto-
skeleton and ECM proteins.
A total of 37 of the 103 rare, deleterious, and destabilizing
nsSNVs occurred in cell lines that were outliers for one or more
phenotype (Figure 5B; Table S6). In Figure 5B, those genes asso-
ciated with PEER Factor 1 are marked in blue, those associated
with PEER Factor 9 in orange, and the gene associated with both
in gray. The phenotypes of cell area, cell roundness, and nucleus
roundness were significantly over-represented in outlier cell lines
with one or more deleterious and destabilizing nsSNV (Fisher’s
exact test comparing the number of outlier cell lines with and
without nsSNVs against non-outlier cell lines) (Figure 5B).
Integrins are heterodimeric proteins that mediate binding to
fibronectin and other extracellular matrix proteins. We identified
a nsSNV in ITGA6, encoding the a6 integrin subunit, in yuze_1,
which maps to the integrin ligand-binding domain (Figures 5B–
5D). Consistent with the predicted deleterious effect of this mu-
tation, Yuze_1 is an outlier for cell roundness andwidth-to-length
ratio (Figure 5B) and shows reduced spreading, particularly on
the lowest concentration of fibronectin (Figure 2; Figure 5C). We
also found a nsSNV in the ligand-binding domain of ITGB1, en-
coding the b1 integrin subunit, in one of the HipSci cell lines,
ffdc_11, that had not been included in the phenotypic screen.
When plated on fibronectin, the ffdc_11 line also exhibited
reduced attachment and spreading on the lowest fibronectin
concentration (Figure 5C), indicative of the predicted outlier
phenotype. Thus, we were able to predict outlier cell behavior
based on a nsSNV in an integrin gene.
DISCUSSION
Genetic mapping provides an unbiased approach to discovering
genes that influence disease traits and responses to environ-
mental stimuli, such as drug exposure (McCarthy et al., 2008).
The attractions of developing human in vitro models that reflect
in vivo genetics and physiology for mechanistic studies are
obvious and include quantitation by high-content image analysis
and the replacement of animal experiments. The concept that
human-disease-causing mutations result in alterations in cell
behavior that can be detected in culture is well established, as
in the case of keratin mutations affecting the properties of
cultured epidermal cells (Kno¨bel et al., 2015). In addition, human
lymphoblastoid cell lines have long been used to model geno-
type-phenotype relationships in healthy individuals, although
limitations include the confounding effects of biological noise
and differentiation state, and variation in passage number and
proliferation rate (Choy et al., 2008; Jack et al., 2014).
There has been renewed interest in applying human iPSCs for
pharmacogenomics, disease modeling, and uncovering genetic
modifiers of complex disease traits (Barral and Kurian, 2016). For
example, studies with iPSC-derived neurons (Brennand and
Gage, 2011) support the ‘‘watershedmodel’’ (Cannon and Keller,
2006), whereby many different combinations of malfunctioning
genes disrupt a few essential pathways to result in the disease.
For these reasons, we decided to extend the iPSC approach in
an attempt to identify genetic modifiers of cell behavior in healthy
individuals. We have recently reported that in an analysis of over
700 well-characterized human iPSC lines, there is an 8%–23%
genetic contribution to variation in cell behavior (Kilpinen
et al., 2017). Our ability to detect this contribution depended
on the use of simple, short-term, quantitative assays of cell
behavior; the application of multiple environmental stimuli
(different concentrations of fibronectin; single cells versus cell
clumps); and homogeneous starting cell populations for the as-
says. The concept that genetic background contributes to the
variability of human iPSCs is supported by a number of earlier
studies (Kytta¨la¨ et al., 2016; Burrows et al., 2016; Rouhani
et al., 2014).
In order to explore the nature of the genetic contribution to
variation in cell behavior, we developed computational ap-
proaches to integrate genomic, gene expression, and cell
biology datasets. Previously, we had taken a GWAS approach
(Kilpinen et al., 2017) and found only 6 variants where the lead
expression quantitative trait locus (eQTL) variant was identical
to a cataloged GWAS variant, including an eQTL variant for the
TERT gene. This was one of our motivations for developing
different approaches. We applied a dimensionality reductionapproach, PEER, to capture variance due to extrinsic contribu-
tors (different fibronectin concentrations) and genetic concor-
dance. This revealed a robust correlation between RNA expres-
sion and the phenotypic features in a large panel of iPSC lines,
with the expression of specific RNAs associated with intrinsic
or extrinsic factors. Carcamo-Orive et al. (2017) also found that
human iPSC lines retain a donor-specific gene expression
pattern. However, in that study, cells were not exposed to
different environmental stimuli.
The majority of human iPSCs we screened responded in the
same way to a given FN concentration. This likely reflects canal-
isation, the process by which normal organs and tissues are pro-
duced even on a background of slight genetic abnormalities
(Rutherford and Lindquist, 1998; McLaren, 1999). However, we
did identify cell lines that exhibited outlier behavior that could
not be accounted for by variation in gene expression levels
(see Figure 4), leading us to hypothesize that outlier phenotypes
might correlate with genetic variants. We identified rare nsSNVs
that were predicted to be deleterious and for which protein struc-
tural informationwas available. Some of the nsSNVs identified by
this approach occurred in cell lines that were outliers for one or
more phenotypes, such as cell spreading. The phenotypes of
cell area, cell roundness, and nucleus roundness were signifi-
cantly over-represented in outlier cell lines with one or more
deleterious and destabilizing nsSNV. The identification of
nsSNVs in integrin genes is of particular interest, because integ-
rins are highly polymorphic and some of the previously reported
nsSNVs alter adhesive functions of cancer cells (Ferreira et al.,
2009; Evans et al., 2003).
In conclusion, our platform has been successful in associating
specific RNAs with intrinsic or extrinsic factors and discovering
nsSNVs that correlate with outlier cell behavior. This represents
a major advance in attempts to map genetic variation to pheno-
typic variation.STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d CONTACT FOR REAGENT AND RESOURCE SHARING
d EXPERIMENTAL MODEL AND SUBJECT DETAILSB Cell line derivation and culture
B Mycoplasma testing and STR profiling
d METHOD DETAILS
B Fibronectin adhesion assays
B Gene expression profiling
B Dimensionality reduction approach
B Gene Ontology analysis
B Single Nucleotide Variation (SNV) analysis
d QUANTIFICATION AND STATISTICAL ANALYSIS
d DATA AND SOFTWARE AVAILABILITYSUPPLEMENTAL INFORMATION
Supplemental Information can be found with this article online at https://doi.
org/10.1016/j.celrep.2019.01.094.Cell Reports 26, 2078–2087, February 19, 2019 2085
CONSORTIA
The members of HipSci can be viewed at https://journals.plos.org/plosone/
article/file?id=10.1371/journal.pone.0155014.s003&type=supplementary.
ACKNOWLEDGMENTS
Weare grateful to theWellcome Trust andMRC for funding through the Human
Induced Pluripotent Stem Cell Initiative (WT098503). We also gratefully
acknowledge funding from the Department of Health by the National Institute
for Health Research comprehensive Biomedical Research Centre award to
Guy’s & St Thomas’ National Health Service Foundation Trust in partnership
with King’s College London and King’s College Hospital NHS Foundation
Trust. The views expressed are those of the author(s) and not necessarily those
of the NHS, the NIHR or the Department of Health. A.V. and N.M.L. gratefully
acknowledge the support of The Francis Crick Institute, which receives its core
funding from Cancer Research UK (FC001110), the UK Medical Research
Council (FC001110), and the Wellcome Trust (FC001110). We thank members
of the Centre for Stem Cells and Regenerative Medicine for scientific discus-
sions and Mia Gervasio, Sabrina Munir, Ayaulim Nurgozhina, Fatima Chowd-
hury, Darrick Hansen, Zuming Tang, Christopher Sibley-Allen, and FranMolina
for technical support. F.M.W. is grateful to Mark Walport for making this
research possible.
AUTHOR CONTRIBUTIONS
F.M.W.: conceptualization; A.V., A. Leha, A. Laddach, A.G., E.W., F.F., and
O.S.: formal analysis; N.M., R.M., O.J.C., A.K., C.H., A.V., M.T., and D.D.:
investigation; E.B., P.W.Z., and HipSci consortium: resources; A.V., N.M.L.,
D.D., and F.M.W.: writing; and R.D. and F.M.W.: funding acquisition.
DECLARATION OF INTERESTS
F.M.W. is currently on secondment as Executive Chair, Medical Research
Council.
Received: June 18, 2018
Revised: December 11, 2018
Accepted: January 24, 2019
Published: February 19, 2019
REFERENCES
Altschul, S.F., Madden, T.L., Scha¨ffer, A.A., Zhang, J., Zhang, Z., Miller, W.,
and Lipman, D.J. (1997). Gapped BLAST and PSI-BLAST: a new generation
of protein database search programs. Nucleic Acids Res. 25, 3389–3402.
1000 Genomes Project Consortium; Auton, A., Brooks, L.D., Durbin, R.M.,
Garrison, E.P., Kang, H.M., Korbel, J.O., Marchini, J.L., McCarthy, S., McVean,
G.A., and Abecasis, G.R. (2015). A global reference for human genetic varia-
tion. Nature 526, 68–74.
Barral, S., and Kurian, M.A. (2016). Utility of induced pluripotent stem cells for
the study and treatment of genetic diseases: focus on childhood neurological
disorders. Front. Mol. Neurosci. 9, 78.
Berman, H., Henrick, K., and Nakamura, H. (2003). Announcing the worldwide
Protein Data Bank. Nat. Struct. Biol. 10, 980.
Brennand, K.J., and Gage, F.H. (2011). Concise review: the promise of human
induced pluripotent stem cell-based studies of schizophrenia. Stem Cells 29,
1915–1922.
Burrows, C.K., Banovich, N.E., Pavlovic, B.J., Patterson, K., Gallego Romero,
I., Pritchard, J.K., and Gilad, Y. (2016). Genetic variation, not cell type of origin,
underlies the majority of identifiable regulatory differences in iPSCs. PLoS
Genet. 12, e1005793.
Cannon, T.D., and Keller, M.C. (2006). Endophenotypes in the genetic ana-
lyses of mental disorders. Annu. Rev. Clin. Psychol. 2, 267–290.2086 Cell Reports 26, 2078–2087, February 19, 2019Carcamo-Orive, I., Hoffman, G.E., Cundiff, P., Beckmann, N.D., D’Souza, S.L.,
Knowles, J.W., Patel, A., Papatsenko, D., Abbasi, F., Reaven, G.M., et al.
(2017). Analysis of transcriptional variability in a large human iPSC library re-
veals genetic and non-genetic determinants of heterogeneity. Cell Stem Cell
20, 518–532.e9.
Choi, J., Goh, G., Walradt, T., Hong, B.S., Bunick, C.G., Chen, K., Bjornson,
R.D., Maman, Y., Wang, T., Tordoff, J., et al. (2015). Genomic landscape of
cutaneous T cell lymphoma. Nat. Genet. 47, 1011–1019.
Choy, E., Yelensky, R., Bonakdar, S., Plenge, R.M., Saxena, R., De Jager, P.L.,
Shaw, S.Y., Wolfish, C.S., Slavik, J.M., Cotsapas, C., et al. (2008). Genetic
analysis of human traits in vitro: drug response and gene expression in lym-
phoblastoid cell lines. PLoS Genet. 4, e1000287.
DeBoever, C., Li, H., Jakubosky, D., Benaglio, P., Reyna, J., Olson, K.M.,
Huang, H., Biggs, W., Sandoval, E., D’Antonio, M., et al. (2017). Large-scale
profiling reveals the influence of genetic variation on gene expression in human
induced pluripotent stem cells. Cell Stem Cell 20, 533–546.e7.
Evans, R.D., Perkins, V.C., Henry, A., Stephens, P.E., Robinson, M.K., and
Watt, F.M. (2003). A tumor-associated beta 1 integrin mutation that abrogates
epithelial differentiation control. J. Cell Biol. 160, 589–596.
Ferreira, M., Fujiwara, H., Morita, K., andWatt, F.M. (2009). An activating beta1
integrin mutation increases the conversion of benign to malignant skin tumors.
Cancer Res. 69, 1334–1342.
Finn, R.D., Clements, J., and Eddy, S.R. (2011). HMMER web server: interac-
tive sequence similarity searching. Nucleic Acids Res. 39, W29–37.
Finn, R.D., Coggill, P., Eberhardt, R.Y., Eddy, S.R., Mistry, J., Mitchell, A.L.,
Potter, S.C., Punta, M., Qureshi, M., Sangrador-Vegas, A., et al. (2016). The
Pfam protein families database: towards a more sustainable future. Nucleic
Acids Res. 44 (D1), D279–D285.
Gonza´lez-Pe´rez, A., and Lo´pez-Bigas, N. (2011). Improving the assessment of
the outcome of nonsynonymous SNVs with a consensus deleteriousness
score, Condel. Am. J. Hum. Genet. 88, 440–449.
Huber, W., von Heydebreck, A., S€ultmann, H., Poustka, A., and Vingron, M.
(2002). Variance stabilization applied to microarray data calibration and to
the quantification of differential expression. Bioinformatics 18 (Suppl 1),
S96–S104.
Jack, J., Rotroff, D., and Motsinger-Reif, A. (2014). Lymphoblastoid cell lines
models of drug response: successes and lessons from this pharmacogenomic
model. Curr. Mol. Med. 14, 833–840.
Kang, H.M., Ye, C., and Eskin, E. (2008). Accurate discovery of expression
quantitative trait loci under confounding from spurious and genuine regulatory
hotspots. Genetics 180, 1909–1925.
Kilpinen, H., Goncalves, A., Leha, A., Afzal, V., Alasoo, K., Ashford, S., Bala, S.,
Bensaddek, D., Casale, F.P., Culley, O.J., et al. (2017). Common genetic vari-
ation drives molecular heterogeneity in human iPSCs. Nature 546, 370–375.
Kno¨bel, M., O’Toole, E.A., and Smith, F.J. (2015). Keratins and skin disease.
Cell Tissue Res. 360, 583–589.
Kytta¨la¨, A., Moraghebi, R., Valensisi, C., Kettunen, J., Andrus, C., Pasumarthy,
K.K., Nakanishi, M., Nishimura, K., Ohtaka, M., Weltner, J., et al. (2016). Ge-
netic variability overrides the impact of parental cell type and determines
iPSC differentiation potential. Stem Cell Reports 6, 200–212.
Lane, S.W., Williams, D.A., and Watt, F.M. (2014). Modulating the stem cell
niche for tissue regeneration. Nat. Biotechnol. 32, 795–803.
Laurent, L.C., Ulitsky, I., Slavin, I., Tran, H., Schork, A., Morey, R., Lynch, C.,
Harness, J.V., Lee, S., Barrero, M.J., et al. (2011). Dynamic changes in the
copy number of pluripotency and cell proliferation genes in human ESCs
and iPSCs during reprogramming and time in culture. Cell Stem Cell 8,
106–118.
Leek, J.T., and Storey, J.D. (2007). Capturing heterogeneity in gene expression
studies by surrogate variable analysis. PLoS Genet. 3, 1724–1735.
Leha, A., Moens, N., Meleckyte, R., Culley, O.J., Gervasio, M.K., Kerz, M., Re-
imer, A., Cain, S.A., Streeter, I., Folarin, A., et al.; HipSci Consortium (2016). A
high-content platform to characterise human induced pluripotent stem cell
lines. Methods 96, 85–96.
Lek, M., Karczewski, K.J., Minikel, E.V., Samocha, K.E., Banks, E., Fennell, T.,
O’Donnell-Luria, A.H., Ware, J.S., Hill, A.J., Cummings, B.B., et al.; Exome Ag-
gregation Consortium (2016). Analysis of protein-coding genetic variation in
60,706 humans. Nature 536, 285–291.
McCarthy, M.I., Abecasis, G.R., Cardon, L.R., Goldstein, D.B., Little, J., Ioan-
nidis, J.P., and Hirschhorn, J.N. (2008). Genome-wide association studies for
complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9,
356–369.
McLaren, A. (1999). Signaling for germ cells. Genes Dev. 13, 373–376.
M€uller, F.J., Schuldt, B.M., Williams, R., Mason, D., Altun, G., Papapetrou,
E.P., Danner, S., Goldmann, J.E., Herbst, A., Schmidt, N.O., et al. (2011). A bio-
informatic assay for pluripotency in human cells. Nat. Methods 8, 315–317.
Notredame, C., Higgins, D.G., and Heringa, J. (2000). T-Coffee: a novel
method for fast and accurate multiple sequence alignment. J. Mol. Biol. 302,
205–217.
Panopoulos, A.D., D’Antonio, M., Benaglio, P., Williams, R., Hashem, S.I.,
Schuldt, B.M., DeBoever, C., Arias, A.D., Garcia, M., Nelson, B.C., et al.
(2017). IPSCORE: a resource of 222 iPSC lines enabling functional character-
ization of genetic variation across a variety of cell types. Stem Cell Reports 8,
1086–1100.
Pashos, E.E., Park, Y., Wang, X., Raghavan, A., Yang, W., Abbey, D., Peters,
D.T., Arbelaez, J., Hernandez, M., Kuperwasser, N., et al. (2017). Large,
diverse population cohorts of hiPSCs and derived hepatocyte-like cells reveal
functional genetic variation at blood lipid-associated loci. Cell Stem Cell 20,
558–570.e10.
Pires, D.E.V., Ascher, D.B., and Blundell, T.L. (2014). DUET: a server for pre-
dicting effects of mutations on protein stability using an integrated computa-
tional approach. Nucleic Acids Res. 42, W314–9.
Rashid, S.T., Corbineau, S., Hannan, N., Marciniak, S.J., Miranda, E., Alex-
ander, G., Huang-Doran, I., Griffin, J., Ahrlund-Richter, L., Skepper, J., et al.
(2010). Modeling inherited metabolic disorders of the liver using human
induced pluripotent stem cells. J. Clin. Invest. 120, 3127–3136.Reimer, A., Vasilevich, A., Hulshof, F., Viswanathan, P., van Blitterswijk, C.A.,
de Boer, J., and Watt, F.M. (2016). Scalable topographies to support
proliferation and Oct4 expression by human induced pluripotent stem cells.
Sci. Rep. 6, 18948.
Robinton, D.A., and Daley, G.Q. (2012). The promise of induced pluripotent
stem cells in research and therapy. Nature 481, 295–305.
Rouhani, F., Kumasaka, N., de Brito, M.C., Bradley, A., Vallier, L., and Gaffney,
D. (2014). Genetic background drives transcriptional variation in human
induced pluripotent stem cells. PLoS Genet. 10, e1004432.
Rutherford, S.L., and Lindquist, S. (1998). Hsp90 as a capacitor formorpholog-
ical evolution. Nature 396, 336–342.
Shen, M.Y., and Sali, A. (2006). Statistical potential for assessment and predic-
tion of protein structures. Protein Sci. 15, 2507–2524.
Stegle, O., Kannan, A., Durbin, R., and Winn, J. (2008). Accounting for non-ge-
netic factors improves the power of eQTL studies. In Research in Computa-
tional Molecular Biology. RECOMB 2008, M. Vingron and L. Wong, eds.
(Springer), pp. 411–422.
Stegle, O., Parts, L., Piipari, M., Winn, J., and Durbin, R. (2012). Using proba-
bilistic estimation of expression residuals (PEER) to obtain increased power
and interpretability of gene expression analyses. Nat. Protoc. 7, 500–507.
The UniProt Consortium. (2017). UniProt: the universal protein knowledge-
base. Nucleic Acids Res. 45 (D1), D158–D169.
Wang, K., Li, M., and Hakonarson, H. (2010). ANNOVAR: functional annotation
of genetic variants from high-throughput sequencing data. Nucleic Acids Res.
38, e164.
Warren, C.R., O’Sullivan, J.F., Friesen, M., Becker, C.E., Zhang, X., Liu, P.,
Wakabayashi, Y., Morningstar, J.E., Shi, X., Choi, J., et al. (2017). Induced
pluripotent stem cell differentiation enables functional validation of GWAS var-
iants in metabolic disease. Cell Stem Cell 20, 547–557.e7.
Webb, B., and Sali, A. (2016). Comparative protein structure modeling using
MODELLER. Curr. Protoc. Bioinformatics 54, 5.6.1–5.6.37.Cell Reports 26, 2078–2087, February 19, 2019 2087
STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Oct4 Santa Cruz Sc5279
NANOG Abcam Ab80892
Chemicals, Peptides, and Recombinant Proteins
Human plasma fibronectin Corning 356008
ROCK inhibitor Enzo Y-27632
Accutase Biolegend 423201
Click-iT EdU kit Life Technologies C10337
CellMask Life Technologies C10046
DAPI ThermoFisher D1306
Deposited Data
Gene expression https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-4057/ N/A
Image data resource https://idr.openmicroscopy.org/webclient/?show=screen-2051 Idr0037
Experimental Models: Cell Lines
Human iPSCs https://www.sanger.ac.uk/science/collaboration/hipsci Table S1
Oligonucleotides
50GGGAGCAAACAGGATTAGATACCCT30 Sigma Mycoplasma FW
50TGCACCATCTGTCACTCTGTTAACCTC30 Sigma Mycoplasma Rev
Probe Hs04260367_gH Taqman ThermoFisher Oct4
Software and Algorithms
Harmony v4.1 software https://support.myharmony.com/en-gb/ Perkin Elmer
Gene Ontology http://cbl-gorilla.cs.technion.ac.il/ N/ACONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Fiona
Watt (fiona.watt@kcl.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell line derivation and culture
All HipSci samples were collected from consented research volunteers recruited from the NIHR Cambridge BioResource (https://
www.cambridgebioresource.group.cam.ac.uk/). Human iPSC were generated from fibroblasts by transduction with Sendai vectors
expressing hOCT3/4, hSOX2, hKLF4, and hc-MYC (CytoTune, Life Technologies, Cat. no. A1377801). Cells were cultured on irradi-
ated orMitomycin C-treatedmouse embryonic fibroblasts (MEF-CF1) in advancedDMEM (Life technologies, UK) supplemented with
10%Knockout Serum Replacement (KOSR, Life technologies, UK), 2 mM L-glutamine (Life technologies, UK) 0.007% 2-mercaptoe-
thanol (Sigma-Aldrich, UK), 4 ng/mL recombinant Fibroblast Growth Factor-2, and 1% Pen/Strep (Life technologies, UK). Pluripo-
tency was assessed based on expression profiling (M€uller et al., 2011), detection of pluripotency markers in culture and response
to differentiation inducing conditions (Robinton and Daley, 2012). Established iPSC lines were passaged every 3-4 days approxi-
mately at a 1:3 split ratio. The ID numbers and details for each cell line are listed in Table S1.
Mycoplasma testing and STR profiling
For mycoplasma testing 1 mL of conditioned medium was heated for 5min at 95C. A PCR reaction was set up with the following
primers: forward (50GGGAGCAAACAGGATTAGATACCCT30); reverse (50TGCACCATCTGTCACTCTGTTAACCTC30). PCR products
were loaded on a 1% w/v agarose gel, run at 110 V for 30 minutes in TAE buffer and observed with a Gel Dox XR+ imaging system
(Bio-Rad). To confirm cell line identity, DNA extraction was performed using the DNeasy Blood & Tissue Kit (QIAGEN). Confluent cells
were dissociated from 6-well plates and lysed in protein K solution; 4 mL of 100mg/ml RNase solution (QIAGEN) was added and DNAe1 Cell Reports 26, 2078–2087.e1–e3, February 19, 2019
was purified through the spin-column and eluted in 150 ml. DNA quality was confirmed with a nanodrop spectrophotometer (Nano-
drop 2000, Thermo scientific) and on a 1% agarose gel. DNA samples were sequenced using STR profiling at the Wellcome Trust
Sanger Institute.
METHOD DETAILS
Fibronectin adhesion assays
96-well micro-clear-black tissue culture plates (Greiner cat. No. 655090) were coated with three concentrations of human plasma
fibronectin (Corning) in alternating columns in a randomized fashion (Leha et al., 2016). Cells were incubated for 8 min with Accutase
(Biolegend) to create a single cell suspension. As the cells began to separate and round up, pre-warmed medium containing 10 mM
Rho- associated protein kinase (ROCK) inhibitor (Y-27632; Enzo Life Sciences) was added and cells were removed from culture wells
by gentle pipetting to form a single cell suspension. Cells were then collected by centrifugation, aspirated and resuspended in me-
dium containing 10 mM ROCK inhibitor. Cells were counted using a Scepter 2.0 automated cell- counting device (Millipore) and
seeded onto the fibronectin- coated 96-well plates using Viaflo (INTEGRA Biosciences) electronic pipettes.
Cell line plating was randomized within rows, with three wells per condition for each line to obviate edge and position effects. One
control line (A1ATD-iPSC patient 1) (Rashid et al., 2010), kindly provided by S. Tamir Rashid and Ludovic Vallier, was run as an internal
control in the majority of plates. For each well, 3,000 cells were plated for 24 hours prior to fixation. Paraformaldehyde 8% (PFA,
Sigma–Aldrich) was added to an equal volume of medium for a final concentration of 4%, and left at room temperature for
15 min. Cells were labeled with EdU (Click-iT, Life Technologies) 30 minutes before fixation. Fixed cells were blocked and permea-
bilised with 0.1% v/v Triton X-100 (Sigma–Aldrich), 1% w/v bovine serum albumin (BSA, Sigma–Aldrich) and 3%v/v donkey serum
(Sigma–Aldrich) for 20 min at room temperature and stained with DAPI (1 microM final concentration, Life Technologies) and cell
mask (1:1000, Life Technologies). EdU was detected according to the manufacturer’s instructions, except that the concentration
of the azide reagent was reduced by 50%.
Images were acquired using an Operetta (Perkin Elmer) high content device. Border wells were avoided to reduce edge effects.
Harmony v4.1 software was used to derive measurements for each cell. Measurements included intensity features (DAPI, EdU),
morphology features (cell area, cell roundness, cell width to length ratio, nucleus area, nucleus roundness, nucleus width to length
ratio) and context features related to cell adhesion properties (number of cells per clump). Processing quantification and normaliza-
tion of data were performed as previously described (Leha et al., 2016).
Gene expression profiling
Gene expression profiles were measured with Illumina HumanHT-12 v4 Expression BeadChips and processed as described by
Kilpinen et al., (2017). Probe intensity estimates were normalized separately for the two cell types using the variance-stabilizing trans-
formation implemented in the R/Bioconductor vsn package (Huber et al., 2002). After normalization, the datasets were limited to the
final remapped set of probes (n probes = 25,604). We refer to this version of the gexarray data as vsn log2 (iPSC/somatic). PEER
analysis was performed taking as input the vsn expression values with the following parameters: K = 36; covariates = cell line and
batch; maximum iterations = 10,000. The residual gene expression matrix was used to perform a correlation analysis with both
intrinsic/extrinsic factors and raw phenotypes using cor() function in R (method Spearman’s).
Dimensionality reduction approach
We applied a Bayesian factor analysis model called PEER (Stegle et al., 2012) to the phenotype data in each cell line. This approach
uses an unsupervised linear model to account for global variance components in the data, and yields a number of factor components
that can be used as synthetic phenotypes in further analysis. We tested a wide range of parameter settings for the model (the k
number), controlling the amount of variance explained by it. We ran PEER with the full pre-normalized dataset with the following
parameters: K = 9; covariates = cell line, fibronectin and batch; maximum iterations = 10,000.
Gene Ontology analysis
Gene Ontology analysis was performed using the Gorilla web-service (http://cbl-gorilla.cs.technion.ac.il/) and the output was visu-
alizedwith ReviGO (http://revigo.irb.hr/). Three analyseswere performed separately for the genes correlating with the extrinsic factor,
the intrinsic factor and both factors.
Single Nucleotide Variation (SNV) analysis
All nsSNVs identified from the ‘‘INFO_04_filtered’’ VCF files from the latest release of the exomeseq data, which have been filtered for
higher confidence variants using Impute2, were mapped to protein sequences using ANNOVAR (Wang et al., 2010). Those nsSNVs
that mapped to genes in our set of genes were selected for further analysis.
Rare nsSNVs were defined as those with aminor allele frequency (MAF) < 0.005 in both the 1000 Genomes Project (1000 Genomes
Project Consortium, 2015) and ExAC database (Lek et al., 2016). Protein domain boundaries were obtained by scanning UNIPROT
(The UniProt Consortium, 2017) protein sequences against the PFAM (Finn et al., 2016) seed libraries using HMMER (Finn et al.,
2011). UniProt proteins (with mapped nsSNVs) were assigned resolved protein structures/homologs from the PDB biounit databaseCell Reports 26, 2078–2087.e1–e3, February 19, 2019 e2
(Berman et al., 2003) using BLAST (Altschul et al., 1997). BLAST searches were carried out using both the entire protein sequences
and domain sequences.
For each protein with mapped nsSNVs the structural homolog with the highest identity was chosen as a template for homology
modeling. In the case of ties the modeling process was performed using each template. The portion of the template and query
sequences relating to a BLAST hit were aligned using T-COFFEE (Notredame et al., 2000). 10 homology models for each query tem-
plate alignment were created using the MODELER software (Webb and Sali, 2016). In each case the model with the lowest zDOPE
score (Shen and Sali, 2006) was selected for further analysis. Wheremodels were created using several templates themodel with the
lowest zDOPE out of all created models was selected for further analysis.
The impact of all nsSNVs was assessed using a primarily sequence-based consensus predictor of deleteriousness, Condel
(Gonza´lez-Pe´rez and Lo´pez-Bigas, 2011). Where structural information was available, the impact of nsSNVs on protein structural
stability was also predicted using DUET (Pires et al., 2014).
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantification and normalization of cell phenotype data were performed as previously described (Leha et al., 2016). For gene expres-
sion analysis a p value threshold < 0.05 was applied to select the statistically significant correlations and the cut-off of the correlation
values was set to ± 0.2. Hits in the BLAST SNV analysis were accepted with a sequence identity > 30% and E-value < 0.001.
DATA AND SOFTWARE AVAILABILITY
New cell phenotype data have been deposited in an online database in conjunction with the research reported in this paper. The raw
image cell phenotypes data are available in the Image Data Resource idr0037 https://idr.openmicroscopy.org/webclient/?
show=screen-2051 following on from the previous dataset https://doi.org/10.17867/10000107. Open access gene expression array
data are available in the ArrayExpress database (https://www.ebi.ac.uk/arrayexpress/) under accession number https://www.ebi.ac.
uk/arrayexpress/experiments/E-MTAB-4057/. TheGorilla web-service for GeneOntology analysis is available at http://cbl-gorilla.cs.
technion.ac.il/ and the ReviGO visualization tool is available at http://revigo.irb.hr/.e3 Cell Reports 26, 2078–2087.e1–e3, February 19, 2019
